DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rose 4.52% to $552.06 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,707.98 and the Dow Jones Industrial Average rising 0.22% to 53,463.05.
This was the stock's third consecutive day of gains.
Vertex Pharmaceuticals Inc. hit a new 52-week high, surpassing its previous peak of $546.17, which the company achieved on August 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as AbbVie Inc. $(ABBV)$ rose 2.72% to $265.97, Krystal Biotech Inc. (KRYS) rose 3.16% to $343.34, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 25.21% to $10.28.
Trading volume (1.4 M) remained 170,463 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.